|
Market Closed -
Nasdaq
01:30:00 12/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 6.390 USD | -1.39% |
|
-5.89% | +60.55% |
| Market Cap | 9.57Cr 8.25Cr 7.81Cr 7.08Cr 13Cr 914.68Cr 13Cr 93Cr 36Cr 465.35Cr 36Cr 35Cr 1.47TCr | P/E 2024 |
-5.14x | P/E 2025 | -20.8x |
|---|---|---|---|---|---|
| Enterprise Value | 9.45Cr 8.14Cr 7.71Cr 6.99Cr 13Cr 902.6Cr 13Cr 92Cr 35Cr 459.2Cr 35Cr 35Cr 1.45TCr | EV / Sales 2024 |
0.95x | EV / Sales 2025 | 1.31x |
| Free-Float |
57.75% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CPIX | Delayed | |
CBOE
| CPIX | Real-time |
Last Transcript : Cumberland Pharmaceuticals Inc.
| 1 day | -1.39% | ||
| 1 week | -5.89% | ||
| Current month | -4.48% | ||
| 1 month | -19.72% | ||
| 3 months | +12.70% | ||
| 6 months | +107.47% | ||
| Current year | +60.55% |
| 1 week | 6.24 |  | 6.88 |
| 1 month | 6.24 | | 9.28 |
| Current year | 2.69 | | 9.28 |
| 1 year | 1.85 | | 9.28 |
| 3 years | 1.04 | | 9.28 |
| 5 years | 1.04 | | 9.28 |
| 10 years | 0 | | 9.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 67 | 07/01/1999 |
John Hamm
DFI | Director of Finance/CFO | 70 | 17/05/2021 |
Shayla Simpson
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CHM | Chairman | 67 | 07/01/1999 |
| Director/Board Member | 74 | 10/09/2010 | |
James Jones
BRD | Director/Board Member | 78 | 01/01/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/03/26 | Free | Executive/Senior Manager | 3,000 | 0.0201% | ||
| 18/03/26 | Free | Director | 5,800 | 0.0388% | ||
| 18/03/26 | Free | Director | 1,800 | 0.0120% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.39% | -5.89% | +86.30% | +289.63% | 9.57Cr | |
| -0.65% | -2.93% | +47.52% | +87.34% | 99TCr | |
| -0.29% | -3.51% | +48.78% | +63.27% | 64TCr | |
| +0.83% | +0.26% | +16.76% | +72.52% | 45TCr | |
| -0.38% | -3.59% | +28.24% | +35.57% | 34TCr | |
| -0.09% | -13.54% | +10.08% | +26.87% | 26TCr | |
| -0.43% | -2.48% | -2.07% | +11.48% | 25TCr | |
| -1.34% | -13.70% | +33.47% | +44.18% | 20TCr | |
| -3.44% | -7.51% | -20.08% | -59.58% | 19TCr | |
| -0.75% | -4.82% | +21.94% | +86.55% | 18TCr | |
| Average | -0.80% | -5.77% | +27.09% | +65.78% | 35.05TCr | |
| Weighted average by Cap. | -0.51% | -4.42% | +29.87% | +55.72% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.79Cr 3.26Cr 3.09Cr 2.8Cr 5.25Cr 361.77Cr 5.28Cr 37Cr 14Cr 184.05Cr 14Cr 14Cr 581.59Cr | 4.45Cr 3.84Cr 3.63Cr 3.29Cr 6.18Cr 425.34Cr 6.21Cr 43Cr 17Cr 216.39Cr 17Cr 16Cr 683.78Cr |
| Net income | -64.8L -55.83L -52.86L -47.92L -89.89L -62Cr -90.35L -6.28Cr -2.41Cr -31Cr -2.43Cr -2.38Cr -100Cr | -28.36L -24.44L -23.14L -20.97L -39.34L -27Cr -39.54L -2.75Cr -1.06Cr -14Cr -1.07Cr -1.04Cr -44Cr |
| Net Debt | 26.08L 22.47L 21.28L 19.29L 36.18L 25Cr 36.37L 2.53Cr 97.18L 13Cr 97.95L 95.81L 40Cr | -12.64L -10.89L -10.31L -9L -17.54L -12Cr -17.63L -1.22Cr -47.1L -6.14Cr -47.48L -46.44L -19Cr |
Employees
88
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | $6.390 | -1.39% | 16,645 |
| 10/26/10 | $6.480 | +3.02% | 41,267 |
| 09/26/09 | $6.290 | -4.98% | 19,735 |
| 08/26/08 | $6.620 | -2.50% | 28,147 |
| 04/26/04 | $6.790 | +0.59% | 14,077 |
- Stock Market
- Stocks
- CPIX Stock
Select your edition
All financial news and data tailored to specific country editions
